Moteur de recherche d’entreprises européennes
UK funding (452 377 £) : Système d’exportation de protéines à vésicule recombinante à rendement exceptionnel pour la recherche et les applications de biotechnologie industrielle. Ukri01/06/2023 UK Research and Innovation, Royaume Uni
Vue d’ensemble
Texte
Système d’exportation de protéines à vésicule recombinante à rendement exceptionnel pour la recherche et les applications de biotechnologie industrielle.
| Abstract | Cells use small membrane bound envelopes, called vesicles, to store and export molecules out of the cell. The ability to reprogram a cell to control this process has huge potential for synthetic biology as it would allow us to harness the cell's machinery for the controlled packaging and release of commercially-valuable molecules neatly packaged into vesicles. This project is based on our discovery of a way to hijack the cell to control this process. This simple and cost-effective invention works by adding a small tag onto the protein. This tag results in bacteria producing huge numbers of these membrane packages filled with the tagged molecules of interest. These packages are exported from the cell into the growth broth, and result in more than a 100-fold increase in protein yield. Protein function is preserved within these packages for months in the fridge. This novel technology represents a major breakthrough in recombinant protein production as it facilitates simple, efficient and rapid purification of diverse proteins for use in biotechnology and medical applications. In this project we will develop this technology and apply it to enhance production and purification of a wide range of biotechnologically and medically important proteins. Working with industry (Fujifilm-Diosynth Biotechnologies) we will optimise the system to large scale fermentation cultures, and develop methods to allow simple and cost-effective purification of the vesicle packaged proteins. Finally, we will extend this recombinant vesicle packaging system to more complex types of cell to further extend the range of therapeutic proteins and downstream applications. Development of this technology will benefit both discovery science and commercial applications, as it will allow scientists to produce biomolecules such as diagnostic and therapeutic antibodies, exported by the cells in a stable environment for easier isolation and storage of proteins. |
| Category | Research Grant |
| Reference | BB/X007448/1 |
| Status | Active |
| Funded period start | 01/06/2023 |
| Funded period end | 16/10/2026 |
| Funded value | £452 377,00 |
| Source | https://gtr.ukri.org/projects?ref=BB%2FX007448%2F1 |
Participating Organisations
| University of Kent | |
| FUJIFILM | |
| FUJIFILM (UK) |
Cette annonce se réfère à une date antérieure et ne reflète pas nécessairement l’état actuel. L’état actuel est présenté à la page suivante : University of Kent, Canterbury, Royaume Uni.
